Abstract
Pyrazolo[4,3-b]indole derivatives have been designed as novel CK2 inhibitor compounds based on the binding mode analysis of a previously reported phenylpyrazole-type CK2 inhibitor. A series of pyrazolo[4,3-b]indoles and related dihydropyrazolo[4,3-b]indoles were efficiently prepared from simple starting materials using a gold-catalysed three-component annulation reaction as a key step. Several of the newly synthesized compounds displayed high levels of inhibitory activity, indicating that the pyrazolo[4,3-b]indole core represents a promising scaffold for the development of potent CK2 inhibitors.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Casein Kinase II / antagonists & inhibitors*
-
Casein Kinase II / metabolism
-
Catalysis
-
Dose-Response Relationship, Drug
-
Gold / chemistry*
-
Humans
-
Indoles / chemical synthesis
-
Indoles / chemistry
-
Indoles / pharmacology*
-
Molecular Structure
-
Protein Kinase Inhibitors / chemical synthesis
-
Protein Kinase Inhibitors / chemistry
-
Protein Kinase Inhibitors / pharmacology*
-
Pyrazoles / chemical synthesis
-
Pyrazoles / chemistry
-
Pyrazoles / pharmacology*
-
Structure-Activity Relationship
Substances
-
Indoles
-
Protein Kinase Inhibitors
-
Pyrazoles
-
Gold
-
Casein Kinase II